Citations (76)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Peggy Spauwen, Bert Ter Mors, Peter van Harten, Anne-Fleur Domensino, Rudolf Ponds & Caroline van Heugten. (2022) Efficacy and safety of amantadine as a treatment for apathy after brain injury: Two single-case experimental design studies. Neuropsychological Rehabilitation 32:6, pages 872-896.
Read now
Read now
Heather M. Ma & Ross D. Zafonte. (2020) Amantadine and memantine: a comprehensive review for acquired brain injury. Brain Injury 34:3, pages 299-315.
Read now
Read now
B.J. Ter Mors, A.P.M. Backx, P. Spauwen, R.W.H.M. Ponds, P.N. Van Harten & C.M. Van Heugten. (2019) Efficacy of amantadine on behavioural problems due to acquired brain injury: A systematic review. Brain Injury 33:9, pages 1137-1150.
Read now
Read now
A.
T. Lane-Brown & R.
L. Tate. (2009) Apathy after acquired brain impairment: A systematic review of non-pharmacological interventions. Neuropsychological Rehabilitation 19:4, pages 481-516.
Read now
Read now
David B Arciniegas, C Alan Anderson, Jeannie Topkoff & Thomas W McAllister. (2005) Mild traumatic brain injury: a neuropsychiatric approach to diagnosis, evaluation, and treatment. Neuropsychiatric Disease and Treatment 1:4, pages 311-327.
Read now
Read now
Gil Newburn & Deborah Newburn. (2005) Selegiline in the management of apathy following traumatic brain injury. Brain Injury 19:2, pages 149-154.
Read now
Read now
Shari Hughes, Angela Colantonio, P. Lina Santaguida & Thomas Paton. (2005) Amantadine to enhance readiness for rehabilitation following severe traumatic brain injury. Brain Injury 19:14, pages 1197-1206.
Read now
Read now
Hochang B. Lee, Constantine G. Lyketsos & Vani Rao. (2003) Pharmacological management of the psychiatric aspects of traumatic brain injury. International Review of Psychiatry 15:4, pages 359-370.
Read now
Read now
Articles from other publishers (68)
Laiba Azhar, Raphael W. Kusumo, Giovanni Marotta, Krista L. Lanctôt & Nathan Herrmann. (2022) Pharmacological Management of Apathy in Dementia. CNS Drugs 36:2, pages 143-165.
Crossref
Crossref
Bas C. Stunnenberg, Joost BerendsRobert C. Griggs, Jeffrey Statland, Gea Drost, Jane Nikles, Hans GroenewoudBaziel G.M. van EngelenGert Jan van der WiltJoost Raaphorst. (2022) N-of-1 Trials in Neurology. Neurology 98:2.
Crossref
Crossref
Davi Jorge Fontoura Solla & Wellingson Silva Paiva. 2021. Traumatic Brain Injury. Traumatic Brain Injury
179
185
.
Monique A. Pimontel, Dora Kanellopoulos & Faith M. Gunning. (2019) Neuroanatomical Abnormalities in Older Depressed Adults With Apathy: A Systematic Review. Journal of Geriatric Psychiatry and Neurology 33:5, pages 289-303.
Crossref
Crossref
Hye-Geum Kim, Bon-Hoon Koo, Seung Woo Lee & Eun-Jin Cheon. (2019) Apathy syndrome in a patient previously treated with selective serotonin reuptake inhibitors for depression. Yeungnam University Journal of Medicine 36:3, pages 249-253.
Crossref
Crossref
Thida Thant & Joel Yager. (2019) Updating Apathy: Using Research Domain Criteria to Inform Clinical Assessment and Diagnosis of Disorders of Motivation. Journal of Nervous & Mental Disease 207:9, pages 707-714.
Crossref
Crossref
Ginger Polich, Mary Alexis Iaccarino & Ross Zafonte. 2019. Psychopharmacology of Neurologic Disease. Psychopharmacology of Neurologic Disease
253
267
.
Angela Scicutella. 2019. Acquired Brain Injury. Acquired Brain Injury
227
301
.
Roberta W. Scherer, Lea Drye, Jacobo Mintzer, Krista Lanctôt, Paul Rosenberg, Nathan Herrmann, Prasad Padala, Olga Brawman-Mintzer, William Burke, Suzanne Craft, Alan J. Lerner, Allan Levey, Anton Porsteinsson & Christopher H. van Dyck. (2018) The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial. Trials 19:1.
Crossref
Crossref
Santiago Perez-Lloret & Olivier Rascol. (2018) Efficacy and safety of amantadine for the treatment of l-DOPA-induced dyskinesia. Journal of Neural Transmission 125:8, pages 1237-1250.
Crossref
Crossref
Justin R. Davanzo & Shelly D. Timmons. 2018. Controversies in Severe Traumatic Brain Injury Management. Controversies in Severe Traumatic Brain Injury Management
179
190
.
Laura L. Frakey. 2018. Encyclopedia of Clinical Neuropsychology. Encyclopedia of Clinical Neuropsychology
293
302
.
Rapson Gomez, Clive Skilbeck, Matt Thomas & Mark Slatyer. (2017) Growth Mixture Modeling of Depression Symptoms Following Traumatic Brain Injury. Frontiers in Psychology 8.
Crossref
Crossref
José R. Maldonado. (2017) Acute Brain Failure. Critical Care Clinics 33:3, pages 461-519.
Crossref
Crossref
Laura L. Frakey. 2017. Encyclopedia of Clinical Neuropsychology. Encyclopedia of Clinical Neuropsychology
1
10
.
Timothy Rittman, Ian TS Coyle-Gilchrist & James B Rowe. (2016) Managing cognition in progressive supranuclear palsy. Neurodegenerative Disease Management 6:6, pages 499-508.
Crossref
Crossref
Larissa Shamseer, Margaret Sampson, Cecilia Bukutu, Christopher H. Schmid, Jane Nikles, Robyn Tate, Bradley C. Johnston, Deborah Zucker, William R. Shadish, Richard Kravitz, Gordon Guyatt, Douglas G. Altman, David Moher, Sunita Vohra, Douglas G. Altman, Cecilia Bukutu, Jocalyn Clark, Elise Cogo, Nicole B. Gabler, Gordon Guyatt, Richard Kravitz, Janine Janosky, Bradley C. Johnston, Bob Li, Jeff Mahon, Robin Marles, David Moher, Jane Nikles, Margaret Sampson, Christopher H. Schmid, William R. Shadish, Larissa Shamseer, Robyn Tate, Sunita Vohra & Deborah Zucker. (2016) CONSORT extension for reporting N-of-1 trials (CENT) 2015: explanation and elaboration. Journal of Clinical Epidemiology 76, pages 18-46.
Crossref
Crossref
Biba R Stanton & Alan Carson. (2016) Apathy: a practical guide for neurologists. Practical Neurology 16:1, pages 42-47.
Crossref
Crossref
D. Plantier & J. Luauté. (2016) Drugs for behavior disorders after traumatic brain injury: Systematic review and expert consensus leading to French recommendations for good practice. Annals of Physical and Rehabilitation Medicine 59:1, pages 42-57.
Crossref
Crossref
M. V. Chelyapina, E. V. Sharova & O. S. Zaytsev. (2016) The cholinergic deficiency syndrome in patients with depressed consciousness after severe brain injury. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 116:7, pages 17.
Crossref
Crossref
T.T.-J. Chong & M. Husain. 2016. Motivation - Theory, Neurobiology and Applications. Motivation - Theory, Neurobiology and Applications
389
426
.
Dennis J. ZgaljardicGary S. SealeLynn A. SchaeferRichard O. TempleJack ForemanTimothy R. Elliott. (2015) Psychiatric Disease and Post-Acute Traumatic Brain Injury. Journal of Neurotrauma 32:23, pages 1911-1925.
Crossref
Crossref
Elizabeth R. Skidmore, Ellen M. Whyte, Meryl A. Butters, Lauren Terhorst & Charles F. ReynoldsIIIIII. (2015) Strategy Training During Inpatient Rehabilitation May Prevent Apathy Symptoms After Acute Stroke. PM&R 7:6, pages 562-570.
Crossref
Crossref
David Moore. 2015. Psychiatry. Psychiatry
1647
1705
.
Joseph H. Friedman. (2014) Withdrawing amantadine in dyskinetic patients with Parkinson disease: The AMANDYSK trial. Neurology 83:11, pages 1035-1036.
Crossref
Crossref
Flora M. Hammond, Allison K. Bickett, James H. Norton & Rashmi Pershad. (2014) Effectiveness of Amantadine Hydrochloride in the Reduction of Chronic Traumatic Brain Injury Irritability and Aggression. Journal of Head Trauma Rehabilitation 29:5, pages 391-399.
Crossref
Crossref
Gary R. Turner & Mark D'Esposito. 2014. Textbook of Neural Repair and Rehabilitation. Textbook of Neural Repair and Rehabilitation
489
499
.
. 2014. Textbook of Neural Repair and Rehabilitation. Textbook of Neural Repair and Rehabilitation
437
508
.
Sergio E. Starkstein & Jaime Pahissa. (2014) Apathy Following Traumatic Brain Injury. Psychiatric Clinics of North America 37:1, pages 103-112.
Crossref
Crossref
Fabienne Ory-MagneJean-Christophe CorvolJean-Philippe AzulayAnne-Marie BonnetChristine Brefel-CourbonPhilippe DamierEstelle DellapinaAlain DestéeFranck DurifMonique GalitzkyThibaud LebouvierWassilios MeissnerClaire ThalamasFrançois TisonAlexandrine SalisAgnès SommetFrançois VialletMarie VidailhetOlivier Rascol. (2014) Withdrawing amantadine in dyskinetic patients with Parkinson disease. Neurology 82:4, pages 300-307.
Crossref
Crossref
Lea T. Drye, Roberta W. Scherer, Krista L. Lanctôt, Paul B. Rosenberg, Nathan Herrmann, David Bachman & Jacobo E. Mintzer. (2013) Designing a Trial to Evaluate Potential Treatments for Apathy in Dementia: The Apathy in Dementia Methylphenidate Trial (ADMET). The American Journal of Geriatric Psychiatry 21:6, pages 549-559.
Crossref
Crossref
Sergio E. Starkstein & Daniel Tranel. 2012. Neurobiology of Psychiatric Disorders. Neurobiology of Psychiatric Disorders
53
74
.
Robert A. Mitchell, Nathan Herrmann & Krista L. Lanctôt. (2011) The Role of Dopamine in Symptoms and Treatment of Apathy in Alzheimer's Disease. CNS Neuroscience & Therapeutics 17:5, pages 411-427.
Crossref
Crossref
Ashok Krishnamoorthy & David Craufurd. (2011) Treatment of Apathy in Huntington’s Disease and Other Movement Disorders. Current Treatment Options in Neurology 13:5, pages 508-519.
Crossref
Crossref
Amanda T. Lane-Brown & Robyn L. Tate. (2012) Apathy After Traumatic Brain Injury: An Overview of the Current State of Play. Brain Impairment 12:1, pages 43-53.
Crossref
Crossref
V. F. J. Newcombe, J. G. Outtrim, D. A. Chatfield, A. Manktelow, P. J. Hutchinson, J. P. Coles, G. B. Williams, B. J. Sahakian & D. K. Menon. (2011) Parcellating the neuroanatomical basis of impaired decision-making in traumatic brain injury. Brain 134:3, pages 759-768.
Crossref
Crossref
Laura L. Frakey. 2011. Encyclopedia of Clinical Neuropsychology. Encyclopedia of Clinical Neuropsychology
210
217
.
Ricardo E Jorge, Sergio E Starkstein & Robert G Robinson. (2010) Apathy following Stroke. The Canadian Journal of Psychiatry 55:6, pages 350-354.
Crossref
Crossref
Peter Frommelt & Hubert LössleinJonathan J. Evans. 2010. NeuroRehabilitation. NeuroRehabilitation
135
144
.
Shinya Ishii, Nancy Weintraub & James R. Mervis. (2009) Apathy: A Common Psychiatric Syndrome in the Elderly. Journal of the American Medical Directors Association 10:6, pages 381-393.
Crossref
Crossref
Amanda Lane-Brown & Robyn Tate. (2009) Interventions for apathy after traumatic brain injury. Cochrane Database of Systematic Reviews.
Crossref
Crossref
José R. Maldonado. (2008) Pathoetiological Model of Delirium: a Comprehensive Understanding of the Neurobiology of Delirium and an Evidence-Based Approach to Prevention and Treatment. Critical Care Clinics 24:4, pages 789-856.
Crossref
Crossref
Brian Levine, Gary R. Turner & Donald T. Stuss. 2015. Cognitive Neurorehabilitation. Cognitive Neurorehabilitation
464
486
.
Nathan Herrmann, Lana S. Rothenburg, Sandra E. Black, Michelle Ryan, Barbara A. Liu, Usoa E. Busto & Krista L. Lanctôt. (2008) Methylphenidate for the Treatment of Apathy in Alzheimer Disease. Journal of Clinical Psychopharmacology 28:3, pages 296-301.
Crossref
Crossref
Robert M. Roth, Laura A. Flashman & Thomas W. McAllister. (2008) Apathy and its treatment. Current Treatment Options in Neurology 9:5, pages 363-370.
Crossref
Crossref
Robert M. Roth, Laura A. Flashman & Thomas W. McAllister. (2007) Apathy and its treatment. Current Treatment Options in Neurology 9:5, pages 363-370.
Crossref
Crossref
Chiadi U. Onyike, Jeannie-Marie E. Sheppard, JoAnn T. Tschanz, Maria C. Norton, Robert C. Green, Martin Steinberg, Kathleen A. Welsh-Bohmer, John C. Breitner & Constantine G. Lyketsos. (2007) Epidemiology of Apathy in Older Adults: The Cache County Study. The American Journal of Geriatric Psychiatry 15:5, pages 365-375.
Crossref
Crossref
Carolyn L Villareal. (2016) Amantadine Therapy in Traumatic Brain Injury Patients. Journal of Pharmacy Technology 23:2, pages 95-103.
Crossref
Crossref
ANGELA SCICUTELLA. 2007. Acquired Brain Injury. Acquired Brain Injury
81
121
.
Shawn J. Kile. (2006) DIAGNOSIS AND TREATMENT OF POSTCONCUSSIVE NEUROBEHAVIORAL SYMPTOMS. CONTINUUM: Lifelong Learning in Neurology 12, pages 60-71.
Crossref
Crossref
Sue R. Beers, Anna Skold, Clifton Edward Dixon & Philip David Adelson. (2005) Neurobehavioral Effects of Amantadine After Pediatric Traumatic Brain Injury. Journal of Head Trauma Rehabilitation 20:5, pages 450-463.
Crossref
Crossref
Ryan C.W. Hall, Richard C.W. Hall & Marcia J. Chapman. (2005) Definition, Diagnosis, and Forensic Implications of Postconcussional Syndrome. Psychosomatics 46:3, pages 195-202.
Crossref
Crossref
Ryan DeMarchi, Vikas Bansal, Anthony Hung, Karol Wroblewski, Hemi Dua, Sanjeev Sockalingam & Shree Bhalerao. (2014) Review of Awakening Agents. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 32:1, pages 4-17.
Crossref
Crossref
Liza B. Green, Joseph E. Hornyak & Edward A. Hurvitz. (2004) Amantadine in Pediatric Patients with Traumatic Brain Injury. American Journal of Physical Medicine & Rehabilitation 83:12, pages 893-897.
Crossref
Crossref
Denise Feil, Jill Razani, Kyle Boone & Ira Lesser. (2003) Apathy and cognitive performance in older adults with depression. International Journal of Geriatric Psychiatry 18:6, pages 479-485.
Crossref
Crossref
Vani Rao & Constantine G Lyketsos. (2002) Psychiatric aspects of traumatic brain injury. Psychiatric Clinics of North America 25:1, pages 43-69.
Crossref
Crossref
David B. Arciniegas, Kerri Held & Peter Wagner. (2002) Cognitive impairment following traumatic brain injury. Current Treatment Options in Neurology 4:1, pages 43-57.
Crossref
Crossref
M.L.C. Labi. (2002) Tratamiento neurofarmacológico tras un traumatismo craneoencefálico. Rehabilitación 36:6, pages 364-372.
Crossref
Crossref
R. Terré, A. Pérez, T. Roig, M. Bernabéu & S. Ramón. (2002) Tratamiento farmacológico con amantadina en pacientes con lesión cerebral. Rehabilitación 36:1, pages 13-17.
Crossref
Crossref
Tilman WetterlingTilman Wetterling. 2002. Organische psychische Störungen. Organische psychische Störungen
457
483
.
Tilman WetterlingTilman Wetterling. 2002. Organische psychische Störungen. Organische psychische Störungen
281
456
.
Lilian Thorpe & Bernard Groulx. (2014) Depressive Syndromes in Dementia. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 28:S1, pages S83-S95.
Crossref
Crossref
Thé‐Phung To, Joan T Tierney & Malcolm J Hopwood. (2000) Serotonergic and Dopaminergic Agents Facilitate Rehabilitation Following Hypoxic Brain Injury. The Australian Journal of Hospital Pharmacy 30:5, pages 202-205.
Crossref
Crossref
S. Al-Adawi, G.S. Dawe & A.A. Al-Hussaini. (2000) Aboulia: neurobehavioural dysfunction of dopaminergic system?. Medical Hypotheses 54:4, pages 523-530.
Crossref
Crossref
Vani Rao & Constantine Lyketsos. (2000) Neuropsychiatric Sequelae of Traumatic Brain Injury. Psychosomatics 41:2, pages 95-103.
Crossref
Crossref
Steven R. Flanagan. (2014) Psychostimulant Treatment of Stroke and Brain Injury. CNS Spectrums 5:3, pages 59-69.
Crossref
Crossref
Ross Beckley & Barbara Fisher. 1998. Attention Deficit Disorder. Attention Deficit Disorder.
W.Jerry Mysiw & M.Elizabeth Sandel. (1997) The agitated brain injured patient. Part 2: Pathophysiology and treatment. Archives of Physical Medicine and Rehabilitation 78:2, pages 213-220.
Crossref
Crossref